Literature DB >> 8778159

Ultrastructural evidence of thyroid damage in amiodarone-induced thyrotoxicosis.

E Cappiello1, R Boldorini, A Tosoni, S Piraneo, R Bernasconi, U Raggi.   

Abstract

Amiodarone-induced thyrotoxicosis occurs in 2-12.1% of patients on chronic amiodarone treatment. In most cases its pathogenesis is related to iodine overload in the presence of preexisting thyroid abnormalities, such as multinodular or diffuse goiter or autonomous nodule. A minority of patients show apparently normal glands or pictures of non-autoimmune thyroiditis. However, there is recent evidence of a direct toxic effect of amiodarone, with consequent release of iodothyronines into the circulation. We report a patient with amiodarone-induced thyrotoxicosis with toxic thyroid effects demonstrated by electron microscopy in a fine-needle aspiration biopsy. There were three main pathologic findings: multilamellar lysosomal inclusions, intramitchondrial glycogen inclusions--both ultrastructural findings indicating thyroid cell damage--and a microscopic morphological pattern of thyroid cell hyperfunction. No inflammatory changes were found. Plasma thyroglobulin levels were high. The patient proved to be a non responder to simultaneous administration of methimazole (starting dose 30 mg/day) and potassium perchlorate (1000 mg/day for 40 days), while still taking amiodarone, thus providing evidence against a possible pathogenetic role of iodine overload. Dexamethasone (starting dose 3 mg/day) was added to methimazole. After three months euthyroidism had been restored and plasma thyroglobulin level substantially decreased. Subsequent subclinical hypothyroidism developed, which persisted after stopping antithyroid treatment and required substitution treatment with levothyroxine. In view of the primary role of lysosome function in the proteolysis of thyroglobulin molecules and of the energy-requiring carrier-mediated transport of monoiodotyrosine across the lysosomal membrane for iodine salvage and reutilization, we suggest that the pathological lysosomal and mitochondrial changes observed could be an ultrastructural marker for subsequent hypothyroidism in amiodarone-induced thyrotoxicosis. Our observations suggest the usefulness of ultrastructural thyroid evaluation and serial plasma thyroglobulin determinations to thoroughly evaluate the underlying pathogenetic mechanisms in amiodarone-associated thyrotoxicosis with apparently normal thyroid glands. Moreover, more knowledge of its pathogenesis could improve both prognostic stratification and treatment guides.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8778159     DOI: 10.1007/BF03349834

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  35 in total

1.  Serum thyroglobulin concentration may be a clue to the mechanism of amiodarone-induced thyrotoxicosis.

Authors:  J Unger
Journal:  J Endocrinol Invest       Date:  1988-10       Impact factor: 4.256

Review 2.  Euthyroid hyperthyroxinemia.

Authors:  R Rajatanavin; L E Braverman
Journal:  J Endocrinol Invest       Date:  1983-12       Impact factor: 4.256

3.  Goiter and hypothyroidism during re-treatment with amiodarone in a patient who previously experienced amiodarone-induced thyrotoxicosis.

Authors:  J Kaplan; S Ish-Shalom
Journal:  Am J Med       Date:  1991-06       Impact factor: 4.965

4.  Amiodarone pulmonary toxicity: functional and ultrastructural evaluation.

Authors:  F L Liu; R D Cohen; E Downar; J W Butany; J D Edelson; A S Rebuck
Journal:  Thorax       Date:  1986-02       Impact factor: 9.139

Review 5.  [Amiodarone and thyroid: the Janus effect].

Authors:  J Unger
Journal:  Rev Med Brux       Date:  1990-04

6.  Treatment of amiodarone induced hyperthyroidism with potassium perchlorate and methimazole during amiodarone treatment.

Authors:  L J Reichert; H A de Rooy
Journal:  BMJ       Date:  1989-06-10

7.  Iodine-induced thyrotoxicosis in apparently normal thyroid glands.

Authors:  J C Savoie; J P Massin; P Thomopoulos; F Leger
Journal:  J Clin Endocrinol Metab       Date:  1975-10       Impact factor: 5.958

8.  Effect of amiodarone on the phospholipid and lamellar body content of lymphoblasts in vitro and peripheral blood lymphocytes in vivo.

Authors:  K Y Hostetler; J Vande Berg; K A Aldern; G T Brophy
Journal:  Biochem Pharmacol       Date:  1991 Mar 15-Apr 1       Impact factor: 5.858

9.  Incidence, predictability, and pathogenesis of amiodarone-induced thyrotoxicosis and hypothyroidism.

Authors:  M D Trip; W Wiersinga; T A Plomp
Journal:  Am J Med       Date:  1991-11       Impact factor: 4.965

10.  Thyrotoxicosis followed by hypothyroidism in patients treated with amiodarone. A possible consequence of a destructive process in the thyroid.

Authors:  E Roti; R Minelli; E Gardini; L Bianconi; L E Braverman
Journal:  Arch Intern Med       Date:  1993-04-12
View more
  2 in total

Review 1.  [Therapy related alterations to the thyroid gland].

Authors:  S Y Sheu; S Levin; K W Schmid
Journal:  Pathologe       Date:  2006-02       Impact factor: 1.011

Review 2.  Amiodarone-induced thyroid disorders: a clinical review.

Authors:  K C Loh
Journal:  Postgrad Med J       Date:  2000-03       Impact factor: 2.401

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.